Randolph de la Rosa Rodríguez
AstraZeneca (Brazil)(BR)Alexion Pharma (Switzerland)(CH)
Publications by Year
Research Areas
Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Testicular diseases and treatments, Surgical site infection prevention, Neurofibromatosis and Schwannoma Cases
Most-Cited Works
- → Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort(2020)219 cited
- → Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis(2020)110 cited
- → Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol(2020)55 cited
- → Demonstrating a Long-Coherence Dual-Rail Erasure Qubit Using Tunable Transmons(2024)48 cited
- → Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis(2021)46 cited
- → Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis(2020)46 cited
- → Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort(2021)28 cited
- → Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study(2025)21 cited
- → Annular pancreas in a 24-year-old woman with persistent abdominal pain(2019)5 cited
- Ectopia testicular perineal: presentación de un caso(2008)